Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7420)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2018 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lan L, Liu R, Qin LY, Cheng P, Liu BW, Zhang BY, Ding SZ, Li XL. Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis. World J Gastroenterol 2018; 24(2): 237-247 [PMID: 29375209 DOI: 10.3748/wjg.v24.i2.237] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i2/237.htm |
| Number | Citing Articles |
| 1 |
Elena Konstantina Siapati, Maria G. Roubelakis, George Vassilopoulos. Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?. Cells 2022; 11(15): 2312 doi: 10.3390/cells11152312
|
| 2 |
Fanchen Yan, Jing Li, Wei Zhang. Transplantation of Endothelial Progenitor Cells: Summary and prospect. Acta Histochemica 2023; 125(1): 151990 doi: 10.1016/j.acthis.2022.151990
|
| 3 |
Liping Deng, Bingjie Wu, Kaini Liang, Hongen Liao, Yanan Du. Precise cell therapy for liver fibrosis: Endothelial cell and macrophage therapy. iLIVER 2022; 1(4): 265 doi: 10.1016/j.iliver.2022.11.002
|
| 4 |
Yan Li, Lungen Lu, Xiaobo Cai. Liver Regeneration and Cell Transplantation for End-Stage Liver Disease. Biomolecules 2021; 11(12): 1907 doi: 10.3390/biom11121907
|
| 5 |
Jingguo Li, Biguang Tuo, Stefano Gitto. Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6612892
|
| 6 |
Asmaa R. Ellakany, Hanan El Baz, Zeinab S. Shoheib, Mohamed Elzallat, Dalia S. Ashour, Nabila A. Yassen. Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals. Pathogens and Global Health 2023; : 1 doi: 10.1080/20477724.2023.2240085
|
| 7 |
Marina Vilaseca, Jordi Gracia-Sancho. Portal Hypertension VII. 2022; : 201 doi: 10.1007/978-3-031-08552-9_18
|
| 8 |
Caecilia H. C. Sukowati, Claudio Tiribelli. Cell Biology and Translational Medicine, Volume 17. Advances in Experimental Medicine and Biology 2022; 1401: 57 doi: 10.1007/5584_2022_719
|
| 9 |
Xiaoli Rong, Yanyan Yang, Guokun Zhang, Haiying Zhang, Chunyi Li, Yimin Wang. Antler stem cells as a novel stem cell source for reducing liver fibrosis. Cell and Tissue Research 2020; 379(1): 195 doi: 10.1007/s00441-019-03081-z
|
| 10 |
Mariia Zadorozhna, Sante Di Gioia, Massimo Conese, Domenica Mangieri. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Molecular Biology Reports 2020; 47(3): 2279 doi: 10.1007/s11033-020-05290-0
|
| 11 |
Daphne Pinheiro, Isabelle Dias, Karina Ribeiro Silva, Ana Carolina Stumbo, Alessandra Thole, Erika Cortez, Lais de Carvalho, Ralf Weiskirchen, Simone Carvalho. Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview. Cells 2019; 8(11): 1339 doi: 10.3390/cells8111339
|
| 12 |
Narjes Nasiri-Ansari, Theodoros Androutsakos, Christina-Maria Flessa, Ioannis Kyrou, Gerasimos Siasos, Harpal S. Randeva, Eva Kassi, Athanasios G. Papavassiliou. Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. Cells 2022; 11(16): 2511 doi: 10.3390/cells11162511
|
| 13 |
Alejandra Garcia-Botella, Patricia Sáez-Carlin, Ramiro Méndez, Maria Paz Martin, Luis Ortega, Jose Vicente Méndez, Beatriz García-Paredes, L Diez-Valladares, Antonio Jose Torres. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial. Surgical Oncology 2020; 33: 224 doi: 10.1016/j.suronc.2019.10.005
|
| 14 |
Jin-Long He, Yi-Xian You, Xiong Pei, Wei Jiang, Qing-Min Zeng, Bin Chen, Yong-Hong Wang, En-Qiang Chen, Hong Tang, Xiu-Feng Gao, Dong-Bo Wu. Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments. Stem Cell Reviews and Reports 2024; 20(2): 447 doi: 10.1007/s12015-023-10659-2
|
| 15 |
Zhaoguo Liu, Song Zhou, Ya Zhang, Ming Zhao. Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00432-4
|